Identification of distinct circulating exosomes in Parkinson’s disease

Annals of Clinical and Translational Neurology

Volumn 2, Issue 4, 2015, Pages 353-361

  Tomlinson, Paul R ^a   Zheng, Ying ^a   Fischer, Roman ^b   Heidasch, Ronny ^a   Gardiner, Chris ^a   Evetts, Samuel ^a   Hu, Michele ^a   Wade Martins, Richard ^a   Turner, Martin R ^a   Morris, John ^a   Talbot, Kevin ^a   Kessler, Benedikt M ^a,b   Tofaris, George K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; BALANCED SALT SOLUTION; GLUCOSYLCERAMIDASE; SYNTENIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOGENESIS; BRAIN CELL; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; EXOSOME; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; MALE; MASS SPECTROMETRY; MEMBRANE MICROPARTICLE; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEOMICS;

EID: 84930580867     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.175     Document Type: Article

References (23)

1. Tofaris GK. Lysosome-dependent pathways as a unifying theme in Parkinson’s disease. Mov Disord 2012;27:1364–9.
2. Shannon KM, Keshavarzian A, Dodiya HB, et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord 2012;27:716–719.
3. Besong-Agbo D, Wolf E, Jessen F, et al. Naturally occurring a-synuclein autoantibody levels are lower in patients with Parkinson disease. Neurology 2013;8:169– 175.
4. Scherzer CR, Eklund AC, Morse LJ, et al. Molecular markers of early Parkinson’s disease based on gene expression in blood. Proc Natl Acad Sci USA 2007;104:955–960.
5. EL Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013;12: 347–357.
6. Katsuda T, Kosaka N, Ochiya T. The role of extracellular vesicles in cancer biology: towards the development of novel cancer biomarkers. Proteomics 2014;14: 412–425.
7. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470–1476.
8. Gardiner C, Ferreira YJ, Dragovic RA, et al. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles 2013;15:2.
9. Fischer R, Trudgian DC, Wright C, et al. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol Cell Proteomics 2012;11:M111.
10. Fruhbeis C, Frohlich D, Kuo WP, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 2013;11:e1001604.
11. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;3.22.1–3.22.29.
12. States DJ, Omenn GS, Blackwell TW, et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 2006;24:333–338.
13. Fu Q, Garnham CP, Elliot ST, et al. A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics 2005;5:2656– 2664.
14. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012;40(Database issue): D1241–D1244.
15. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012;14:677–685.
16. Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341–345.
17. Danzer KM, Kranich LR, Ruf WP, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 2012;7:42.
18. Shi M, Changqin Liu C, Cook TJ, et al. Plasma exosomal a-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol 2014;128: 639–650.
19. Chiasserini D, van Weering JRT, Piersma SR, et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics 2014;106:191–204.
20. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654–659.
21. Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 1997;94: 13683–13688.
22. Chivet M, Javalet C, Laulagnier K, et al. Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons. J Extracell Vesicles 2014;3:24722. doi: 10.3402/jev.v3.24722
23. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 2014;3:24641.